Key result
Capecitabine induced severe coronary vasospasm mimicking acute coronary syndrome in a 74-year-old woman with pancreatic adenocarcinoma and no pre-existing coronary artery disease.
Why the study?
To highlight severe side effects of capecitabine and prevent misdiagnosis in patients presenting with acute coronary syndrome.
Case Report (n=1)
No
Capecitabine can induce severe coronary artery vasospasm mimicking acute coronary syndrome even in patients without prior coronary heart disease.
Answers are grounded in this paper and cite their sources.
May prompt consideration of capecitabine-induced vasospasm in ACS differentials among oncology patients; leaves open incidence, risk factors, and surveillance needs.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Savić et al. (2024) conducted a case report in Pancreatic adenocarcinoma (n=1). Capecitabine was evaluated on Coronary vasospasm. Capecitabine induced severe coronary vasospasm mimicking acute coronary syndrome in a 74-year-old woman with pancreatic adenocarcinoma and no pre-existing coronary artery disease.
Synapse has enriched 10 related papers. Consider them for comparative context: